One Health Trust

Each year, #bacterialinfections cause an estimated 7.7 million deaths, with nearly 5 million linked to drug-resistant bacteria. The Lancet has published a series of papers, with experts brought together by OHT’s Dr. Ramanan Laxminarayan, on antimicrobial resistance (AMR). The series elucidates the problem and proposes solutions to the growing threat to #globalhealth. Dr. Iruka Okeke, professor of the Department of Pharmaceutical Microbiology at the University of Ibadan in Nigeria helped write the first of these papers. Listen to the One World, One Health #podcast, as she talks about the growing threat of #AMR to global health and the need for a multifaceted approach to address this issue. Tune in to the episode with subtitles here: https://lnkd.in/guFqq2d9 Learn more about the impactful but achievable targets laid out by the Lancet series authors,10-20-30 by 2030, and what should be considered ahead of the United Nations General Assembly High-Level Meeting on AMR here: https://lnkd.in/dyU7eASR #UNGA2024 #Targets #Drugresistance

Antibiotic resistance hits hardest in low- and middle-income countries with limited healthcare access and sanitation. The Global Antibiotic Resistance Partnership (GARP) is leading efforts to develop actionable policies to tackle these disparities. Currently, GARP is highlighting the potential of vaccines to mitigate antimicrobial resistance (AMR) and its contributing factors. Learn more about GARP’s work here: https://ow.ly/YBMB50SyANU #AntibioticResistance #GARP #Vaccines #PublicHealth #GlobalHealth #AMR

Antimicrobial resistance (AMR) happens when germs evolve to resist medicines, making infections harder to treat and more dangerous. Everyone, including kids, can help stop AMR by preventing infections in the first place. Learn how we can include kids in the fight to control AMR. Learn about OHT’s research on AMR here: https://lnkd.in/dDYA2vg9 #ChildrenHealth #AMR #StayHealthy

Mott MacDonald is bringing together global health experts and implementers to discuss the progress and gaps in implementing the World Health Assembly’s 2015 Global Action Plan on antimicrobial resistance (#AMR), ahead of September’s #UNGA High-Level Meeting on AMR. Join OHT’s Dr. Ramanan Laxminarayan and other global health experts in an online discussion on progress and gaps in implementing the World Health Assembly’s 2015 Global Action Plan, opportunities and challenges for mobilizing political commitment and resources and best practices and lessons learned from successful interventions and challenges for mobilizing political commitment and resources. 🗓️ Tuesday, July 9 ⏰ 11 a.m. -12 p.m. CET Register today: https://mottm.ac/3KM30wR Other Speakers include: - - Dr. Heidi Hopkins, Lead Clinical Microbiologist, Mott MacDonald - Dr. Evelyn Wesangula, Senior Project Officer – AMR, East Central and Southern Africa Health Community - Prof. Rungtip Chuanchuen, Department of Veterinary Public Health, Faculty of Veterinary Science, Chulalongkorn University #UnitedNationsGeneralAssembly #AMRInsights

In "The Lancet Series on Antimicrobial Resistance: The need for sustainable access to effective antibiotics," authored by experts convened by OHT's Dr. Ramanan Laxminarayan, the authors propose achievable targets of 10-20-30 by 2030 to tackle the #AMR issue. These targets align with the global effort to combat AMR, with the United Nations High-Level Meeting on AMR taking place in September 2024. Learn more about these targets in The Lancet series here: https://ow.ly/oLvH50SwHIn #UNGA2024 #Goals #EndAMR #GlobalHealth

The new The Lancet Series on Antimicrobial Resistance – written by experts brought together by OHT's Dr. Ramanan Laxminarayan – sheds light on the significant impact of #AMR on global health and cancer treatment, particularly in low- and middle-income countries. The CEO of Union for International Cancer Control (UICC), Dr Cary Adams, says, "This seminal series is a wake-up call for all of us in the cancer and global health communities. AMR is undermining our hard-won advances against cancer and other deadly diseases. Urgent, coordinated action is needed to address this silent pandemic." Read UICC's welcome message for the series here: https://lnkd.in/eG4iXAq7 Learn about the ambitious but achievable 10-20-30 by 2030 targets laid out by the Lancet authors to push the needle on global AMR control ahead of the United Nation's General Assembly High-Level meeting in September here: https://lnkd.in/dyU7eASR #LancetSeries #AntimicrobialResistance #CancerTreatment

Newborn babies are extremely vulnerable to infections, including sepsis, which affects three million babies annually and causes over half a million deaths. Many of these deaths occur due to the unavailability of effective antibiotics, a problem worsened by drug-resistant infections. Listen to this episode of One World, One Health with Professor Mike Sharland, a pediatric infectious disease specialist at St. George's University of London, as he tells us about the terrifying growth of drug-resistant infections in newborns and the need for better antibiotics for vulnerable babies. Tune in: https://lnkd.in/dqkBn4NQ #NeonatalCare #AntibioticResistance #InfectiousDiseases

The One Health Trust organized the launch of The Lancet Series on Antimicrobial Resistance: Sustainable Access to Effective Antibiotics on May 28, 2024. The event highlighted data, evidence, and policy recommendations aimed at forming the cornerstone for a United Nations resolution addressing antimicrobial resistance ahead of the 2024 UN General Assembly High-Level Meeting on antimicrobial resistance. Missed the event? Watch it here: https://ow.ly/vN2650SvIM5 #AntimicrobialResistance #AMR #LancetSeries #OneHealthTrust #PublicHealth #Healthcare #UNGA2024

What did disruptions in food, health, and economic systems during the COVID-19 pandemic do to childhood nutrition? In our recent study published in Nature Communications Medicine , children surveyed after the pandemic began in 2020 had decreased height and weight when compared to pre-pandemic measurements. In 2021, these outcomes improved but some outcomes, primarily weight, did not recover completely. Reductions were greatest in the poorest households.  Covid may have left long term damage in ways that will persist but fortunately the short term effects seems to have disappeared quite rapidly Arindam Nandi Amit Summan One Health Trust

OHT’s Ramanan Laxminarayan co-authored a qualitative, exploratory study exploring barriers to implementing environmental surveillance of antibiotic resistance in low- and middle-income countries. Using a constructivist grounded theory approach, researchers identified infrastructural, institutional, and sociocultural obstacles. Key informants highlighted issues like disorganized resources, bureaucracy, and corruption. Suggested solutions include simplifying methods, local collaboration, and increased funding. Experts in high-income countries could support local collaborators and facilities to optimize environmental surveillance efforts, improving global antibiotic resistance mitigation. Read the article, published in Global Health Action, here: https://lnkd.in/dZSEyrX4 #LMICs #EnvironmentalSurveillance #AntibioticResistance